BVS 241115 22.50P (BVS241115P22500) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

BVS241115P22500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 15 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Earnings Call: Bioventus Reports Robust Q3 Growth, Raises Full-year Guidance
InvestingNov 6 13:24 ET
Bioventus Is Maintained at Buy by Canaccord Genuity
Dow JonesNov 6 12:58 ET · Ratings
Bioventus Analyst Ratings
BenzingaNov 6 12:47 ET · Ratings
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Announces Target Price $17
Moomoo NewsNov 6 09:33 ET · Ratings
CCORF Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $15
Moomoo NewsNov 6 08:37 ET · Ratings
J.P. Morgan Maintains Bioventus(BVS.US) With Sell Rating, Announces Target Price $12
Moomoo NewsNov 6 07:31 ET · Ratings

Comments

Jsmooth420365

Sep 4 05:27

$Bioventus (BVS.US)$ WTH you get 6 from?.. is that where you shorted at? 🤦‍♂️🤣

Jsmooth420365

Sep 2 00:27

$Bioventus (BVS.US)$ thinking about opening up a small swing over 10.30 🤔 lots of resistance to the left tho..

Stock Region

May 7 13:55

Healing Solutions Company Announces Earnings: Beats Analyst Consensus By 200%

The company’s quarterly sales reached $129.457 million, exceeding the analyst consensus estimate of $118.380 million by 9.36 percent.
Bioventus Inc. (Nasdaq: BVS), a company in the field of active healing solutions, has recently announced its financial outcomes for the quarter ending March 30, 2024, displaying remarkable performance and growth that has surpassed expectations on multiple fronts. The company's earnings pe...

Kanasai

May 7 06:50

$Bioventus (BVS.US)$ Target 6

TIPSY

Mar 8 09:53

$Bioventus (BVS.US)$ 7.5